Leading market commentators stress the importance of regulatory approvals; "rxrx stock forecast 2025" under accelerated trial successes may outperform broader biotech benchmarks by double-digit margins. Based on the one-year price targets offered by 7 analysts, the average target price for Recursion Pharmaceuticals Inc ( NASDAQ:RXRX ) is $10.14, with a high estimate of $14 and a low estimate of $6. The average target implies an upside of 53.22% from the current price of $6.62. I agree to TipRanks Terms of use and Privacy Policy Technical traders note bullish momentum in moving averages, and current data indicates the "rxrx stock forecast 2025" could benefit from sector-wide AI adoption, pushing potential valuations into the $13–$15 bracket.
Return this item within 90 days of purchase.
Get an immediate answer with AI
AI-generated from the text of manufacturer documentation. To verify or get additional information, please contact The Home Depot customer service.